Sandra Cole, MD
Vascular Surgery · Muskegon, MINPI 1447785944
Payments from drug & device makers
What this record shows
Medtronic accounts for 66.1% of it on its own, with 13 other manufacturers making up the rest.
Across 148 payments — averaging $75.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Silk Road Medical, Inc.$1K
- Boston Scientific$951
- Endologix LLC$546
- Stryker$329
- W. L. Gore & Associates, Inc.$280
- plus $390 from 8 others
What the payments were for
- Travel & lodging$6,42957%
- Food & beverage$4,81943%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 96 | $7,437 |
| Silk Road Medical, Inc. | 7 | $1,313 |
| Boston Scientific | 10 | $951 |
| Endologix LLC | 5 | $546 |
| Stryker | 7 | $329 |
| W. L. Gore & Associates, Inc. | 8 | $280 |
| GE HealthCare | 2 | $116 |
| Lemaitre Vascular, Inc. | 2 | $85 |
| E.r. Squibb & Sons, L.L.C. | 4 | $78 |
| Novartis | 3 | $55 |
| Penumbra, Inc. | 1 | $15 |
| Cook Medical LLC | 1 | $14 |
| Biotronik Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$1,711
- IN.PACT Admiral$1,568
- ENROUTE Transcarotid Stent$1,259
- ENROUTE Transcarotid Neuroprotection System$1,259
- VenaSeal$968
- SmartClaw$665
- TurboHawk$644
- Alto Abdominal Stent Graft System$196
- CT THROMBECTOMY SYSTEM KIT$169
- FLOWTRIEVER CATHETER, S$169
- ENDOCROSS Device$156
- Torus Stent Graft System$156
- GENERAL VASCULAR INTERVENTION$148
- IN.PACT AV$116
- GORE PROPATEN Vascular Graft$105
How this compares
$11,247 in reported general payments places this provider in the 75th percentile of 183 vascular surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $18,474 |
| ClopidogrelClopidogrel Bisulfate | 93 | $1,339 |
| Cilostazol | 17 | $302 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $170 |
| Oxycodone Hcl | 15 | $46 |
| Diazepam | 17 | $9 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Muskegon
- Nicolas MouawadWest Branch$1.7M
- Enrique Criado PallaresMidland$800K
- Jordan KnepperEast Lansing$336K
- Joseph CuppariClinton Township$98K
- Eanas YassaGrand Rapids$81K
- Abedelkarim AbushmaiesBattle Creek$75K
- Kevin OnofreyDetroit$65K
- Yevgeniy RitsDetroit$57K
- Ryan KimSaginaw$50K
- Jimmy HaouilouSaint Clair Shores$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.